American Cryostem's Business Segments
American Cryostem's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
American Cryostem does not report a distinct business-segment axis in its filings - its disaggregated revenue is disclosed by product and service category instead. See the Product & Service breakdown below.
Revenue by Product & Service Category - FY
- Health Care Other93.9%
- Product7%
- Royalty0%
Revenue by Product & Service Category - FY
| Category | Revenue (Millions) | % of Total |
|---|---|---|
| Health Care Other | $ 0 | 93.9% |
| Product | $ 0 | 7% |
| Royalty | - | 0% |
Product and service categories are a supplemental disclosure and are not required to sum to consolidated revenue or to the reportable segments above.
Description of American Cryostem
Since its establishment in 2008, American Cryostem has been at the forefront of innovation in the field of regenerative medicine. The company's primary focus is on adipose-derived stem cells (ADSCs), which are obtained from the patient's own fat through a minimally invasive liposuction procedure. These stem cells have the ability to differentiate into various cell types, making them valuable for a wide range of medical applications.
American Cryostem operates a state-of-the-art laboratory facility that follows strict cGMP (current Good Manufacturing Practices) guidelines and utilizes advanced processing techniques to isolate and preserve the stem cells. The company's meticulous procedures ensure the highest quality and viability of the stem cells, making them suitable for clinical applications.
The stem cells collected by American Cryostem are used in numerous medical therapies, such as regenerative medicine for the treatment of degenerative diseases, wound healing, and cosmetic procedures. Additionally, the company's stem cell banking services allow individuals to store their own stem cells for potential future use, providing them with an invaluable insurance policy against potential health issues.
In addition to its core stem cell business, American Cryostem has expanded its operations to include the development of cosmetic products and services. Leveraging their expertise in adipose tissue, the company has introduced a line of skincare products that utilize a unique blend of adipose-derived growth factors and peptides. These products are designed to rejuvenate the skin and promote a youthful appearance.
Furthermore, American Cryostem is actively involved in scientific research collaborations and partnerships with leading academic institutions and hospitals. These collaborations aim to further explore the therapeutic potential of adipose-derived stem cells and promote scientific advancements in the field of regenerative medicine.
Overall, American Cryostem Corporation is a pioneering biotechnology company that is revolutionizing the field of regenerative medicine through its expertise in adipose tissue and stem cell processing. With a commitment to quality, innovation, and scientific collaboration, the company continues to make significant contributions to the development of advanced medical therapies and cosmetic products that enhance people's lives.
Segments
1. Regenerative Medicine:
- This segment is dedicated to therapies aimed at repairing, regenerating, or replacing damaged tissues and organs through the use of stem cells. It encompasses a wide range of applications, including orthopedic, cardiovascular, and cosmetic treatments.
2. Cell Storage Services:
- American Cryostem provides long-term cryogenic storage solutions for stem cells and other biological materials. This service ensures the preservation of cells for potential future medical use, which is particularly important for patients undergoing regenerative therapies.
3. Clinical Research and Development:
- The company is involved in ongoing clinical research to explore new applications for adipose-derived stem cells. This segment focuses on the innovation of therapies and products that can enhance treatment outcomes in various medical fields.
4. Consultation and Training:
- American Cryostem offers consultation services for healthcare providers looking to implement regenerative medicine practices. This includes training on best practices for stem cell collection and processing, regulatory compliance, and patient communication.
Products
1. Adipose-Derived Stem Cells (ADSC):
- The primary product line involves the extraction and processing of adipose-derived stem cells. These stem cells can be utilized in a range of applications, including joint pain relief, skin rejuvenation, and hair restoration.
2. Cryopreservation Vials:
- To facilitate the storage of stem cells, American Cryostem employs state-of-the-art cryopreservation vials specifically designed to maintain cell viability during freezing and thawing processes.
3. Stem Cell Processing Kits:
- The company offers specialized kits for the isolation and processing of adipose-derived stem cells. These kits are designed to streamline the extraction process, making it easier for medical professionals to obtain quality stem cells for treatment purposes.
4. Regenerative Therapy Solutions:
- A line of therapeutic solutions that incorporate stem cells for various treatments, including orthopedic procedures, cosmetic applications, and wound healing therapies.
Services
1. Stem Cell Collection:
- American Cryostem provides services for the collection of adipose tissue from patients, which serves as the source material for stem cell extraction. The procedure is minimally invasive and performed by trained healthcare professionals.
2. Cell Processing:
- After collection, the adipose tissue undergoes processing to extract stem cells. This service includes the preparation of the cells for immediate use or long-term storage.
3. Cryogenic Storage:
- The company maintains a secure cryogenic facility for the long-term storage of collected stem cells. This service ensures that the viability of the cells is preserved, allowing for potential future therapeutic applications.
4. Patient Education and Support:
- American Cryostem emphasizes patient engagement by providing educational resources and support regarding the use of stem cells in regenerative medicine. This includes informing patients about the potential benefits, risks, and procedures involved in stem cell therapies.
5. Investment in Research:
- The company actively collaborates with research institutions to advance the science of regenerative medicine. This includes funding studies and trials to investigate the efficacy of stem cell treatments across various medical disciplines.
Through these segments, products, and services, American Cryostem Corporation aims to position itself as a leader in the field of regenerative medicine, committed to advancing therapeutic options and improving patient outcomes through innovative stem cell applications.
